Akebia Therapeutics (AKBA) Change in Inventory (2019 - 2026)

Akebia Therapeutics (AKBA) has 8 years of Change in Inventory data on file, last reported at $2.5 million in Q1 2026.

• On a quarterly basis, Change in Inventory fell 48.72% year-over-year to $2.5 million in Q1 2026; TTM through Mar 2026 was $20.7 million, a 28.38% decrease from a year earlier, with the FY2025 full-year figure at $23.1 million, down 18.58% from the prior year.
• Change in Inventory for Q1 2026 stood at $2.5 million, down from $17.4 million in the prior quarter.
• Over the last five years, Change in Inventory for AKBA reached as high as $17.4 million in Q4 2025 and fell as low as -$24.5 million in Q4 2022.
• Historically, Change in Inventory has averaged $2.2 million across 5 years, with a median of $2.5 million in 2026.
• Across the five-year window, Change in Inventory surged 528.78% in 2024 and tumbled 1365.87% in 2025, its largest moves.
• Year by year, Change in Inventory stood at -$24.5 million in 2022, then soared by 148.18% to $11.8 million in 2023, then declined by 27.88% to $8.5 million in 2024, then jumped by 105.01% to $17.4 million in 2025, then slumped by 85.42% to $2.5 million in 2026.
• Per Business Quant data, the three most recent Change in Inventory figures were $2.5 million in Q1 2026, $17.4 million in Q4 2025, and -$6.9 million in Q3 2025.